Hologic shares are trading on heavy volume today, having risen 2.5% to $20.51. About 2.9 million shares have been traded today, as compared to the 30-day average volume of 2.3 million shares. Spikes in volume can validate a breakout or signify a potential turning point.
There is potential upside of 23.7% for shares of Hologic based on a current price of $20.51 and an average consensus analyst price target of $25.38. The stock should find initial resistance at its 200-day moving average (MA) of $20.85 and further resistance at its 50-day MA of $21.69.
In the past 52 weeks, Hologic share prices have been bracketed by a low of $13.90 and a high of $23.96 and are now at $20.51, 48% above that low price. The 200-day and 50-day moving averages have moved 0.18% higher and 0.71% lower over the past week, respectively.
Hologic, Inc. develops, manufactures, and markets x-ray systems. The Company makes x-ray bone densitometers that measure the precise bone density for use in the diagnosing of metabolic bone diseases such as osteoporosis.